Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,200 HIV / AIDS
clinical trials

Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use
Status: Enrolling, Phase IV
Updated: 12/31/1969
Fenway Health
mi
from
Boylston, MA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling, Phase
Updated: 12/31/1969
Cleveland Clinic (A2508)
mi
from
Cleveland, OH
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling, Phase
Updated: 12/31/1969
Univ of Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Status: Enrolling, Phase IV
Updated: 12/31/1969
WNE Maternal Pediatric Adolescent AIDS CRS
mi
from
Worcester, MA
Click here to add this to my saved trials
Severe Combined Immunodeficiency Clinical Trial
Genetic Basis of Immunodeficiency
Status: Enrolling, Phase
Updated: 12/31/1969
Universidad de Immunologia
mi
from
Santiago,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hosp. General de Agudos Buenos Aires Argentina NICHD CRS
mi
from
Ciudad de Buenos Aires,
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Midwestern Regional Medical Center
mi
from
Zion, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive Clinical Trial
Natural History Study of SCID Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
Status: Enrolling, Phase
Updated: 12/31/1969
Providence Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Status: Enrolling, Phase I
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hospital General de Agudos Dr. Cosme Argerich
mi
from
Buenos Aires,
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore - Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
ACC Clinic, Jackson Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland Baltimore, Institute of Human Virology CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Inova Heart and Vascular Institute CRS
mi
from
Falls Church, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Clinical Research Center CRS
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai West Samuels CRS
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Infectious Diseases Clinic, Washington DC Veterans Affairs Medical Center CRS
mi
from
Washington DC,
Click here to add this to my saved trials
HIV Clinical Trial
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling, Phase III
Updated: 3/22/2016
Clinical Research P.R., Inc.
mi
from
San Juan,
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling, Phase
Updated: 12/31/1969
Northwell Health, Inc. PRIME
mi
from
Great Neck, NY
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.136 Mecklenburg Medical Group, P.A.
mi
from
Charlotte, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.058
mi
from
Jesup, GA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Kingston, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.006 Spectrum Medical Group
mi
from
Phoenix, AZ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.128 Olmos Park Medical Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
Orlando, FL
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
NC Young Women's CoOp
Status: Enrolling
Updated: 12/31/1969
Guilford County Department of Public Health - Greensboro
mi
from
Greensboro, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Children's Hospital Colorado CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
UCLA Vine Street Clinic CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
JHU HIVTR-CCR5 Non-Network CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
UAB HIVTR-CCR5 Non-Network CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
Mt. Sinai Med. Ctr. HIVTR-CCR5 Non-Network CRS
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ. of Penn HIVTR-CCR5 Non-network CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
HIV Clinical Trial
Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission
Status: Enrolling
Updated: 12/31/1969
Kapsabet Hospital
mi
from
Kapsabet,
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Early ART to Limit Infection and Establishment of Reservoir
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University CRS (2101)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling, Phase IV
Updated: 2/21/2018
Allergy Asthma and Immunology Relief
mi
from
Charlotte, NC
Click here to add this to my saved trials
Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling, Phase III
Updated: 12/31/1969
IMMUNOe Health & Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwell Health, Inc. PRIME
mi
from
Great Neck, NY
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Pediatric Allergy and Immunology
mi
from
Miami, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Reproductive Clinical Trial
Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract
Status: Enrolling, Phase
Updated: 12/31/1969
University of Minnesota-Clinical and Translational Sciences Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling, Phase III
Updated: 11/21/2017
Oklahoma Institute of Allergy Ashma and Immunology
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk
Status: Enrolling
Updated: 12/31/1969
School of Public Health, Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
HIV INfections Clinical Trial
Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks
Status: Enrolling, Phase I
Updated: 1/10/2018
Yale Clinical and Community Research, 270 Congress Ave
mi
from
New Haven, CT
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Prevention and Risk: Treatment With a New Emphasis on Relationships
Status: Enrolling
Updated: 12/31/1969
Center for HIV Educational Studies and Training; Hunter College
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
Status: Enrolling, Phase I, II
Updated: 12/31/1969
AIDS Healthcare Foundation - Public Health Division
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media
Status: Enrolling
Updated: 1/12/2018
Center for Alcohol and Addiction Studies
mi
from
Providence, RI
Click here to add this to my saved trials
HIV Infection Primary Clinical Trial
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities
Status: Enrolling
Updated: 12/31/1969
Center for AIDS Research and Treatment
mi
from
Manhasset, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
Status: Enrolling
Updated: 3/8/2018
LA BioMed
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
Status: Enrolling
Updated: 12/31/1969
The CORE Center, Cook County Health and Hospitals System
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV Clinical Trial
Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol
Status: Enrolling, Phase III
Updated: 12/31/1969
One Community Health
mi
from
Sacramento, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fenway Health
mi
from
Boylston, MA
Click here to add this to my saved trials
HIV Clinical Trial
Siempre Seguiré: A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM
Status: Enrolling
Updated: 4/23/2018
Bienestar Human Services Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
1 … 11 12 13 14 15 16 17 18 19 20 21 22